País: Irlanda
Idioma: inglés
Fuente: HPRA (Health Products Regulatory Authority)
ACICLOVIR
Rowex Ltd
250 Milligram
Unknown
2003-05-02
PART II SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT ACIC 250 mg Powder for Solution for Infusion 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each vial contains 250 mg aciclovir as the freeze-dried sodium salt. For excipients, see 6.1. 3 PHARMACEUTICAL FORM Powder for solution for infusion 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS ACIC is indicated for: 4.2 POSOLOGY AND METHOD OF ADMINISTRATION ROUTE OF ADMINISTRATION: Intravenous. RECOMMENDED DOSAGE SCHEDULE: The required dose of ACIC should be administered by slow intravenous infusion over a one-hour period. A course of treatment with ACIC usually lasts 5 days, but this may be adjusted according to the patient’s condition and response to therapy. Treatment for herpes simplex encephalitis usually lasts 10 days. The duration of prophylactic administration of ACIC is determined by the duration of the period at risk. NON-IMMUNO-COMPROMISED PATIENTS IMMUNO-COMPROMISED PATIENTS Severe initial genital herpes Herpes simplex infection Recurrent varicella Zoster virus infection Primary and recurrent varicella zoster infection Prophylaxis of herpes simplex infection Herpes simplex encephalitis Herpex simplex encephalitis INDICATION IMMUNE STATUS DOSAGE Herpes simplex infections Normal or Immuno-compromised 5 mg/kg every 8 hours Recurrent varicella zoster infections Normal 5 mg/kg every 8 hours Primary and recurrent varicella zoster infections Immuno-compromised 10 mg/kg every 8 hours Herpes simplex encephalitis Normal or Immuno-compromised 10 mg/kg every 8 hours IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 08/03/2007_ _CRN 2034608_ _page number: 1_ Patients with renal impairment should be administered ACIC with caution. The following modifications in Leer el documento completo